发起物多态性 (等位基变异) 通过调节E2F6结合亲和力来影响塔克罗利木斯治疗的有效性
Xinyi Zheng1, Shengying Qin2, Mingkang Zhong1
1Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai 200040, China.
Biomedicines
|January 8, 2025
概括
一种新的PPP3R1基因多态,rs4519508 C > T,通过改变转录因子结合来影响塔克罗利 (TAC) 免疫抑制. 这种遗传变异可能解释了患者对TAC治疗反应的个体差异.
科学领域:
- 药物基因组学 药物基因组学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 塔克罗利 (TAC) 是移植中的重要免疫抑制剂,但由于其狭窄的治疗指数,其有效性因个人而异.
- 识别影响TAC药学动力学的遗传因素对于优化患者的治疗结果至关重要.
研究的目的:
- 为了研究新型PPP3R1促进物多态性的调节作用,rs4519508 C > T,在塔克罗利斯的药理学路径.
- 探索这种多态性对基因表达和对TAC的免疫反应的影响.
主要方法:
- 双露西法酶记者测定和生物信息分析,以评估等位基变异效应.
- 电泳运动转移试验 (EMSA) 用于验证转录因子结合.
- 定量实时PCR (qRT-PCR),ELISA和西部涂抹来确定TAC的免疫抑制作用.
主要成果:
- rs4519508 C > T 多态性显著增强了PPP3R1促进体活性.
- 欧洲安全局证实,转录因子E2F6与野生类型的rs4519508 C等位基因结合,但与突变的T等位基因结合较弱.
- 下调E2F6增加了TAC抑制的下游免疫细胞因子水平,这种影响取决于rs4519508基因型.
结论:
- E2F6抑制PPP3R1的表达;rs4519508的C>T多态性损害了E2F6的结合,增加PPP3R1的水平,减轻了TAC对免疫细胞因子的抑制.
- PPP3R1 rs4519508 C > T 多态是预测移植患者个人塔克罗利斯反应变异性的潜在药理学生物标志物.
相关概念视频
The Eukaryotic Promoter Region
16.1K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
16.1K
Cell Specific Gene Expression
13.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K


